anthranilicacidProperties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsL-M,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Caution
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheissuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:50mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue
.
Application
AnNSAID.CircumventsMRP-mediatedmultidrugresistance.Specificallyandsignificantlypotentiatesthecytotoxicityofanthracyclines(doxorubicin,daunorubicinandepirubicin),aswellasteniposide,VP-16andvincristine.
Safety:
Symbol

GHS07
Precautionarystatements
P301+P312+P330
RIDADR
NONHforallmodesoftransport